Editorial: encouraging results from phase 1/2 COVID-19 vaccine trials

Encouraging results from phase 1/2 COVID-19 vaccine trials – The Lancet

Podcast: The Lancet Editor-in-Chief Richard Horton explains the current status of the Oxford and China COVID-19 vaccines

Commentaries: Promising early findings for 2 more COVID-19 vaccines – CIDRAP AND Expert reaction to two vaccine candidate studies: a phase 1/2 trial of the University of Oxford’s ChAdOx1 vaccine candidate; and a phase 2 trial of China’s Ad5-vectored COVID-19 vaccine candidate – Science Media Centre